Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)

Laura M. Cecere, Christopher G. Slatore, Jane E. Uman, Laura E. Evans, Edmunds M. Udris, Chris L. Bryson, David H. Au

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Long-acting inhaled medications are an important component of the treatment of patients with chronic obstructive pulmonary disease (COPD), yet few studies have examined the determinants of medication adherence among this patient population. Objective: We sought to identify factors associated with adherence to long-acting beta-agonists (LABA) and inhaled corticosteroids (ICS) among patients with COPD. Methods: We performed secondary analysis of baseline data collected in a randomized trial of 376 Veterans with spirometrically confirmed COPD. We used electronic pharmacy records to assess adherence, defined as a medication possession ratio of ≥0.80. We investigated the following exposures: patient characteristics, disease severity, medication regimen complexity, health behaviors, confidence in self-management, and perceptions of provider skill. We performed multivariable logistic regression, clustered by provider, to estimate associations. Results: Of the 167 patients prescribed LABA, 54% (n = 90) were adherent to therapy while only 40% (n = 74) of 184 the patients prescribed ICS were adherent. Higher adherence to LABA and ICS was associated with patient perception of their provider as being an "expert" in diagnosing and managing lung disease For LABA: OR = 21.70 (95% CI 6.79, 69.37); For ICS OR = 7.93 (95 CI 1.71, 36.67). Factors associated with adherence to LABA, but not ICS, included: age, education, race, COPD severity, smoking status, and confidence in self-management. Conclusions: Adherence to long-acting inhaled medications among patients with COPD is poor, and determinants of adherence likely differ by medication class. Patient perception of clinician expertise in lung disease was the factor most highly associated with adherence to long-acting therapies.

Original languageEnglish (US)
Pages (from-to)251-258
Number of pages8
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume9
Issue number3
DOIs
StatePublished - Jun 2012

Fingerprint

Chronic Obstructive Pulmonary Disease
Adrenal Cortex Hormones
Therapeutics
Self Care
Lung Diseases
Medication Adherence
Health Behavior
Veterans
Self Concept
Logistic Models
Smoking
Education
Population

Keywords

  • Chronic disease
  • Medication adherence
  • Pharmacoepidemiology
  • Pulmonary diseases

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). / Cecere, Laura M.; Slatore, Christopher G.; Uman, Jane E.; Evans, Laura E.; Udris, Edmunds M.; Bryson, Chris L.; Au, David H.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, No. 3, 06.2012, p. 251-258.

Research output: Contribution to journalArticle

Cecere, Laura M. ; Slatore, Christopher G. ; Uman, Jane E. ; Evans, Laura E. ; Udris, Edmunds M. ; Bryson, Chris L. ; Au, David H. / Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2012 ; Vol. 9, No. 3. pp. 251-258.
@article{7f4fb90cfc55429db1f844f7755ad5f2,
title = "Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)",
abstract = "Background: Long-acting inhaled medications are an important component of the treatment of patients with chronic obstructive pulmonary disease (COPD), yet few studies have examined the determinants of medication adherence among this patient population. Objective: We sought to identify factors associated with adherence to long-acting beta-agonists (LABA) and inhaled corticosteroids (ICS) among patients with COPD. Methods: We performed secondary analysis of baseline data collected in a randomized trial of 376 Veterans with spirometrically confirmed COPD. We used electronic pharmacy records to assess adherence, defined as a medication possession ratio of ≥0.80. We investigated the following exposures: patient characteristics, disease severity, medication regimen complexity, health behaviors, confidence in self-management, and perceptions of provider skill. We performed multivariable logistic regression, clustered by provider, to estimate associations. Results: Of the 167 patients prescribed LABA, 54{\%} (n = 90) were adherent to therapy while only 40{\%} (n = 74) of 184 the patients prescribed ICS were adherent. Higher adherence to LABA and ICS was associated with patient perception of their provider as being an {"}expert{"} in diagnosing and managing lung disease For LABA: OR = 21.70 (95{\%} CI 6.79, 69.37); For ICS OR = 7.93 (95 CI 1.71, 36.67). Factors associated with adherence to LABA, but not ICS, included: age, education, race, COPD severity, smoking status, and confidence in self-management. Conclusions: Adherence to long-acting inhaled medications among patients with COPD is poor, and determinants of adherence likely differ by medication class. Patient perception of clinician expertise in lung disease was the factor most highly associated with adherence to long-acting therapies.",
keywords = "Chronic disease, Medication adherence, Pharmacoepidemiology, Pulmonary diseases",
author = "Cecere, {Laura M.} and Slatore, {Christopher G.} and Uman, {Jane E.} and Evans, {Laura E.} and Udris, {Edmunds M.} and Bryson, {Chris L.} and Au, {David H.}",
year = "2012",
month = "6",
doi = "10.3109/15412555.2011.650241",
language = "English (US)",
volume = "9",
pages = "251--258",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)

AU - Cecere, Laura M.

AU - Slatore, Christopher G.

AU - Uman, Jane E.

AU - Evans, Laura E.

AU - Udris, Edmunds M.

AU - Bryson, Chris L.

AU - Au, David H.

PY - 2012/6

Y1 - 2012/6

N2 - Background: Long-acting inhaled medications are an important component of the treatment of patients with chronic obstructive pulmonary disease (COPD), yet few studies have examined the determinants of medication adherence among this patient population. Objective: We sought to identify factors associated with adherence to long-acting beta-agonists (LABA) and inhaled corticosteroids (ICS) among patients with COPD. Methods: We performed secondary analysis of baseline data collected in a randomized trial of 376 Veterans with spirometrically confirmed COPD. We used electronic pharmacy records to assess adherence, defined as a medication possession ratio of ≥0.80. We investigated the following exposures: patient characteristics, disease severity, medication regimen complexity, health behaviors, confidence in self-management, and perceptions of provider skill. We performed multivariable logistic regression, clustered by provider, to estimate associations. Results: Of the 167 patients prescribed LABA, 54% (n = 90) were adherent to therapy while only 40% (n = 74) of 184 the patients prescribed ICS were adherent. Higher adherence to LABA and ICS was associated with patient perception of their provider as being an "expert" in diagnosing and managing lung disease For LABA: OR = 21.70 (95% CI 6.79, 69.37); For ICS OR = 7.93 (95 CI 1.71, 36.67). Factors associated with adherence to LABA, but not ICS, included: age, education, race, COPD severity, smoking status, and confidence in self-management. Conclusions: Adherence to long-acting inhaled medications among patients with COPD is poor, and determinants of adherence likely differ by medication class. Patient perception of clinician expertise in lung disease was the factor most highly associated with adherence to long-acting therapies.

AB - Background: Long-acting inhaled medications are an important component of the treatment of patients with chronic obstructive pulmonary disease (COPD), yet few studies have examined the determinants of medication adherence among this patient population. Objective: We sought to identify factors associated with adherence to long-acting beta-agonists (LABA) and inhaled corticosteroids (ICS) among patients with COPD. Methods: We performed secondary analysis of baseline data collected in a randomized trial of 376 Veterans with spirometrically confirmed COPD. We used electronic pharmacy records to assess adherence, defined as a medication possession ratio of ≥0.80. We investigated the following exposures: patient characteristics, disease severity, medication regimen complexity, health behaviors, confidence in self-management, and perceptions of provider skill. We performed multivariable logistic regression, clustered by provider, to estimate associations. Results: Of the 167 patients prescribed LABA, 54% (n = 90) were adherent to therapy while only 40% (n = 74) of 184 the patients prescribed ICS were adherent. Higher adherence to LABA and ICS was associated with patient perception of their provider as being an "expert" in diagnosing and managing lung disease For LABA: OR = 21.70 (95% CI 6.79, 69.37); For ICS OR = 7.93 (95 CI 1.71, 36.67). Factors associated with adherence to LABA, but not ICS, included: age, education, race, COPD severity, smoking status, and confidence in self-management. Conclusions: Adherence to long-acting inhaled medications among patients with COPD is poor, and determinants of adherence likely differ by medication class. Patient perception of clinician expertise in lung disease was the factor most highly associated with adherence to long-acting therapies.

KW - Chronic disease

KW - Medication adherence

KW - Pharmacoepidemiology

KW - Pulmonary diseases

UR - http://www.scopus.com/inward/record.url?scp=84862087720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862087720&partnerID=8YFLogxK

U2 - 10.3109/15412555.2011.650241

DO - 10.3109/15412555.2011.650241

M3 - Article

VL - 9

SP - 251

EP - 258

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 3

ER -